Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jul-24 6:07 PM View:  | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-24 | Option Exercise | 24,476 | -- | -- | < 1% 4.53M to 4.55M | |
| 02-Jul-24 6:12 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Jun-24 | Payment of Exercise | 2,019 | $0.73 | $1,475.89 | (1%) 195.08K to 193.06K | |
| 02-Jul-24 6:08 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-24 | Payment of Exercise | 2,998 | $0.73 | $2,191.54 | (5%) 60.43K to 57.43K | |
| 02-Jul-24 6:12 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Jun-24 | Option Exercise | 8,952 | -- | -- | 5% 186.13K to 195.08K | |
| 02-Jul-24 6:08 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-24 | Option Exercise | 9,957 | -- | -- | 20% 50.47K to 60.43K | |
| 02-Jul-24 6:07 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-24 | Payment of Exercise | 8,684 | $0.73 | $6,348.00 | (< 1%) 4.55M to 4.54M | |
| 21-Jun-24 5:16 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 20-Jun-24 | Purchase | 20,508 | $0.74 | $15,253.80 | 12% 165.62K to 186.13K | |
| 21-Jun-24 5:16 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 18-Jun-24 | Private Purchase | 12,000 | $0.86 | $10,320.00 | 8% 153.62K to 165.62K | |
| 17-Jun-24 6:08 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 17-Jun-24 | Purchase | 12,000 | $0.90 | $10,798.80 | 8% 141.62K to 153.62K | |
| 17-Jun-24 6:08 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 14-Jun-24 | Purchase | 12,000 | $0.93 | $11,175.60 | 9% 129.62K to 141.62K | |
| 17-Jun-24 6:08 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 13-Jun-24 | Private Purchase | 12,000 | $0.91 | $10,920.00 | 10% 117.62K to 129.62K | |
| 05-Jun-24 6:12 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 04-Jun-24 | Purchase | 12,000 | $0.78 | $9,360.00 | 11% 105.62K to 117.62K | |
| 05-Jun-24 6:12 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 03-Jun-24 | Private Purchase | 12,000 | $0.76 | $9,120.00 | 13% 93.62K to 105.62K | |
| 31-May-24 4:56 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-May-24 | Purchase | 12,000 | $0.64 | $7,731.60 | 15% 81.62K to 93.62K | |
| 31-May-24 4:56 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-May-24 | Purchase | 12,000 | $0.64 | $7,676.40 | 17% 69.62K to 81.62K | |
| 31-May-24 4:56 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 29-May-24 | Private Purchase | 12,000 | $0.64 | $7,642.80 | 21% 57.62K to 69.62K | |
| 30-May-24 6:10 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 28-May-24 | Exercise (in-the money or at-the-money) | 84,000 | $0.00 | $84.00 | 2% 4.44M to 4.53M | |
| 02-Apr-24 8:33 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Payment of Exercise | 4,082 | $0.68 | $2,779.84 | (7%) 54.55K to 50.47K | |
| 02-Apr-24 8:33 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Option Exercise | 9,956 | -- | -- | 22% 44.6K to 54.55K | |
| 02-Apr-24 8:35 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Mar-24 | Payment of Exercise | 3,098 | $0.68 | $2,109.74 | (5%) 60.72K to 57.62K | |
| 02-Apr-24 8:33 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Payment of Exercise | 7,172 | $0.68 | $4,884.13 | (< 1%) 4.45M to 4.44M | |
| 02-Apr-24 8:33 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Mar-24 | Option Exercise | 24,474 | -- | -- | < 1% 4.43M to 4.45M | |
| 02-Apr-24 8:35 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Mar-24 | Option Exercise | 8,952 | -- | -- | 17% 51.77K to 60.72K | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Payment of Exercise | 2,327 | $0.34 | $791.65 | (< 1%) 4.43M to 4.43M | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Option Exercise | 6,724 | -- | -- | < 1% 4.42M to 4.43M | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Payment of Exercise | 505 | $0.34 | $171.80 | (1%) 45.1K to 44.6K | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 01-Jan-24 | Option Exercise | 1,231 | -- | -- | 3% 43.87K to 45.1K | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Payment of Exercise | 4,073 | $0.34 | $1,385.63 | (8%) 47.94K to 43.87K | |
| 03-Jan-24 7:34 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 9,957 | -- | -- | 26% 37.99K to 47.94K | |
| 03-Jan-24 7:38 PM View: | Klausner Arthur J Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | < 1% 3.08M to 3.09M | |
| 03-Jan-24 7:39 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 8,952 | -- | -- | 19% 45.92K to 54.87K | |
| 03-Jan-24 7:37 PM View: | Starr Christopher M Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | 3% 72.73K to 75.26K | |
| 03-Jan-24 7:40 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | < 1% 4.51M to 4.51M | |
| 03-Jan-24 7:40 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 2,533 | -- | -- | 10% 24.33K to 26.86K | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Payment of Exercise | 8,469 | $0.34 | $2,881.15 | (< 1%) 4.43M to 4.42M | |
| 03-Jan-24 7:36 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 31-Dec-23 | Option Exercise | 24,474 | -- | -- | < 1% 4.41M to 4.43M | |
| 03-Jan-24 7:39 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 31-Dec-23 | Payment of Exercise | 3,098 | $0.34 | $1,053.94 | (6%) 54.87K to 51.77K | |
| 03-Oct-23 10:00 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Payment of Exercise | 3,444 | $0.62 | $2,134.94 | (8%) 41.43K to 37.99K | |
| 03-Oct-23 10:00 PM View: | Tsuchimoto Kim R Chief Financial Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 9,956 | -- | -- | 32% 31.47K to 41.43K | |
| 03-Oct-23 10:00 PM View: | Klausner Arthur J Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | < 1% 3.08M to 3.08M | |
| 03-Oct-23 10:00 PM View: | Starr Christopher M Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | 4% 70.2K to 72.73K | |
| 03-Oct-23 10:00 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | < 1% 4.51M to 4.51M | |
| 03-Oct-23 10:00 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 2,533 | -- | -- | 12% 21.8K to 24.33K | |
| 03-Oct-23 10:00 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 24,474 | -- | -- | < 1% 4.39M to 4.41M | |
| 03-Oct-23 10:00 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Sep-23 | Payment of Exercise | 2,624 | $0.62 | $1,626.62 | (5%) 48.54K to 45.92K | |
| 03-Oct-23 10:00 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Sep-23 | Payment of Exercise | 7,172 | $0.62 | $4,445.92 | (< 1%) 4.41M to 4.41M | |
| 03-Oct-23 10:00 PM View: | Cittadine Andrew Chief Operating Officer | Monopar Therapeutics (MNPR) | 30-Sep-23 | Option Exercise | 8,953 | -- | -- | 23% 39.59K to 48.54K | |
| 03-Jul-23 6:49 PM View: | Brown Michael J Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 2,534 | -- | -- | < 1% 4.51M to 4.51M | |
| 03-Jul-23 6:50 PM View: | Anderson Raymond Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 2,534 | -- | -- | 13% 19.26K to 21.8K | |
| 03-Jul-23 6:45 PM View: | Robinson Chandler Chief Executive Officer Director | Monopar Therapeutics (MNPR) | 30-Jun-23 | Option Exercise | 35,039 | -- | -- | < 1% 4.36M to 4.4M |
